Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000392922

Medchemexpress LLC Nrf2 degrader 1 | 3025286-00-1 | 98.8% | 826.92 | 50 MG
SDP

Catalog No. 5000392922
Encompass_Preferred

Nrf2 degrader 1 (compound 1) is a PROTAC Nrf2 degrader with a DC50 of 0.1-1 μM in huH1 cells. It inhibits cancer cell growth for A549 and LK-2 cells with IC50 values of 100 nM and 40 nM, respectively. It can be used for the study of liver cancer, non-small cell lung cancer (NSCLC), and squamous cell carcinoma of lung cancer. The compound structure consists of an Nrf2 Target protein ligand, a Cereblon ligand, and a linker. It is intended for research use only.

  • Inhibits cancer cell viability with IC50 values of 100 nM for A549 (lung, carcinoma) and 40 nM for LK-2 (squamous cell carcinoma) after 3 days.

Catalog No. 50-003-92922 Supplier Medchemexpress LLC Supplier No. HY16230750MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Nrf2 degrader 1 (compound 1) is a PROTAC Nrf2 degrader with a DC50 of 0.1-1 μM in huH1 cells. It inhibits cancer cell growth for A549 and LK-2 cells with IC50 values of 100 nM and 40 nM, respectively. It can be used for the study of liver cancer, non-small cell lung cancer (NSCLC), and squamous cell carcinoma of lung cancer. The compound structure consists of an Nrf2 Target protein ligand, a Cereblon ligand, and a linker. It is intended for research use only.

  • Inhibits cancer cell viability with IC50 values of 100 nM for A549 (lung, carcinoma) and 40 nM for LK-2 (squamous cell carcinoma) after 3 days.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.